HDG...Thanks again for your astute, helpful analyses...
You estimate rebates to payers to be at 50% of WAC at a price of 320....This would set the price to payers at about $160/bottle...in line with the prices Amarin can eventually expect from Europe (and perhaps in the future from China)
With increased volumes resulting from lower prices, Amarin can definitely survive with this scenario until the combo drug is approved to rescue the U.S. market from the 'skinny label'.